Related references
Note: Only part of the references are listed.Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles
Nathan Scott et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test
Daniela Amaral Silva et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications
J. Al-Gousous et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer
Daniela Amaral Silva et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Comparison of pH and motility of the small intestine of healthy subjects and patients with symptomatic constipation using the wireless motility capsule
A. Aburub et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance
Jozef Al-Gousous et al.
MOLECULAR PHARMACEUTICS (2018)
Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs
Bart Hens et al.
MOLECULAR PHARMACEUTICS (2017)
Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets
Hiroko Shibata et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Toward Biopredictive Dissolution for Enteric Coated Dosage Forms
J. Al-Gousous et al.
MOLECULAR PHARMACEUTICS (2016)
In Vivo Predictive Dissolution: Transport Analysis of the CO2, Bicarbonate In Vivo Buffer System
Brian J. Krieg et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry
Tongeji Elifazi Tungaraza et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2013)
Evolution of a physiological pH 6.8 bicarbonate buffer system: Application to the dissolution testing of enteric coated products
Fang Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX® with Asacol®
C. Prantera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems
Hala M. Fadda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Review article: oral, modified-release mesalazine formulations - proprietary versus generic
A Forbes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Share Paper
